SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 792.26 |
| Enterprise Value ($M) | 628.62 |
| Book Value ($M) | 463.23 |
| Book Value / Share | 4.34 |
| Price / Book | 1.71 |
| NCAV ($M) | 313.72 |
| NCAV / Share | 2.94 |
| Price / NCAV | 2.53 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.53 |
| Return on Assets (ROA) | -0.52 |
| Return on Equity (ROE) | -0.53 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 9.30 |
| Current Ratio | 9.30 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 378.18 |
| Assets | 527.70 |
| Liabilities | 64.47 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | -273.20 |
| Net Income | -258.75 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -209.72 |
| Cash from Investing | 131.71 |
| Cash from Financing | 185.74 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G | Maverick Capital Ltd | 5.20 | ||
| 13G/A | Wellington Management Group Llp | 13.40 | 24.49 | |
| 13D/A | Rtw Investments, Lp | 17.60 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 283,820 | 1,419,091 | 20.00 | |
| 374,027 | 1,988,058 | 18.81 | |
| 518,252 | 3,024,937 | 17.13 | |
| 541,172 | 3,444,063 | 15.71 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| PTGX – Protagonist Therapeutics, Inc. | RANI – Rani Therapeutics Holdings, Inc. |
| RAPT – RAPT Therapeutics, Inc. | RLAY – Relay Therapeutics, Inc. |
| RNA – Avidity Biosciences, Inc. |